(HealthDay)—A model that uses routine primary care data can predict the risk for advanced liver disease, according to a study published online Feb. 11 in BMJ Open.
Mar 03, 2021
0
5
A dual therapy treatment regimen of expanded-spectrum cephalosporins (ESCs) plus azithromycin (AZM) is the recommended standard of care for gonorrhea. A strain of the Neisseria (N.) gonorrhoeae that is resistant to the ESC ...
Oct 26, 2020
0
7
During the COVID-19 pandemic, words and phrases that have typically been limited to epidemiologists and public health professionals have entered the public sphere. Although we've rapidly accepted epidemiology-based news, ...
Sep 09, 2020
0
5
(HealthDay)—In young people at risk for psychosis, proteomic biomarkers may help to individualize prognosis, according to a study published online Aug. 26 in JAMA Psychiatry.
Aug 28, 2020
0
5
(HealthDay)—A majority of toddlers are being screened for autism spectrum disorder (ASD) during primary care visits, according to a study published online July 6 in Pediatrics.
Jul 06, 2020
0
6
(HealthDay)—Converting genotype information into an interpretable probability value for five different inflammatory arthritis-causing diseases could potentially improve the diagnostic efficiency of rheumatic disease, according ...
May 29, 2020
0
1
For participants without atrial fibrillation, use of a smartwatch application (app) can identify irregular pulse, which may indicate atrial fibrillation with high positive predictive value, according to a study published ...
Nov 14, 2019
0
1
(HealthDay)—A predictive model that uses prenatal risk factors to help identify women at higher risk for admission to the maternal intensive care unit (ICU) has low positive predictive value, according to a study published ...
Jul 26, 2019
0
0
(HealthDay)—A machine learning classifier can effectively identify patients at risk for familial hypercholesterolemia (FH), according to a study published online April 11 in npj Digital Medicine.
Apr 18, 2019
0
0
An analysis of the reports and materials provided by commercial laboratories offering noninvasive prenatal screening (NIPS) for genetic disorders finds that none of them fully meet the recommendations published by the American ...
Apr 02, 2019
0
3
